Clinical Research

Fibronectin as predictor of cirrhosis in men who abuse alcohol

Br Med J (Clin Res Ed) 1988; 296 doi: https://doi.org/10.1136/bmj.296.6637.1629 (Published 11 June 1988) Cite this as: Br Med J (Clin Res Ed) 1988;296:1629
  1. Jette Junge,
  2. Kirsten D Bentsen,
  3. Per Christoffersen,
  4. Marianne Orholm,
  5. Thorkild I A Sørensen,
  6. Thomas Horn

    Abstract

    In a study of 142 male alcohol abusers without evidence of cirrhosis the presence of intralobular fibronectin in the liver was investigated in relation to the subsequent development of the disease. All 142 initial biopsy samples showed preserved architecture. During a follow up period of 10-13 years 23 patients (16%) developed cirrhosis. Twelve of 110 patients with normal or slightly increased amounts of parenchymal fibronectin in the initial biopsy specimen developed cirrhosis, whereas eight out of 27 patients with moderately increased amounts and three out of five with significantly increased amounts later developed the disease (p<0·005).

    Semiquantitative assessment of the amount of parenchymal fibronectin at an early stage of alcoholic liver disease is of definite predictive value for the development of cirrhosis.

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe